2023
Disparities in COVID-19 vaccine hesitancy among a diverse community-based sample in Connecticut, United States
Eger W, Suttiratana S, Herbst R, Behringer H, Ibrahim E, Jones B. Disparities in COVID-19 vaccine hesitancy among a diverse community-based sample in Connecticut, United States. Preventive Medicine Reports 2023, 34: 102263. PMID: 37252068, PMCID: PMC10207837, DOI: 10.1016/j.pmedr.2023.102263.Peer-Reviewed Original ResearchCOVID-19 vaccine hesitancyNon-Hispanic blacksVaccine hesitancyMultivariable logistic regressionDiverse community-based sampleCommunity health workersHispanic/Latinx participantsCOVID-19 infectionCOVID-19Health-related beliefsCommunity-based sampleRace/ethnicityVaccine efficacyCOVID-19 casesHealth workersMore vaccinesSociodemographic factorsHispanic/LatinxConnecticut residentsSocial determinantsLogistic regressionSocioeconomic statusCOVID-19 informationHealthcare systemHealth information
2021
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)
Roth JA, Trivedi MS, Gray SW, Patrick DL, Delaney DM, Watabayashi K, Litwin P, Shah P, Crew KD, Yee M, Redman MW, Unger JM, Papadimitrakopoulou V, Johnson J, Kelly K, Gandara D, Herbst RS, Hershman DL, Ramsey SD. Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN). JCO Oncology Practice 2021, 17: e1821-e1829. PMID: 33797955, PMCID: PMC9810137, DOI: 10.1200/op.20.00770.Peer-Reviewed Original ResearchConceptsMaster protocolsPatient knowledgeCell lung cancerOncology clinical trialsMost participantsMaster protocol trialsMedian ageEligible participantsLung cancerLung-MAPClinical trialsOdds ratioGenomic resultsCancer riskProtocol trialSociodemographic factorsCancer treatmentPilot studyCancer diagnosisTelephone surveyRiskCorrect responsesDemographic factorsCancerDescriptive statistics